This could be explained by an augmented number of astrocytes as well as a higher content of MAO-B in tumoral astrocytes with respect to normal ones [5], highlighting that the overexpression of MAO-B could be related with high-grade glioma, and thus defining MAO-B as a promising target for the development of novel therapies for cancer. This evidence concerns the gene MAOB and glioma.